Health Biotchnology Portfolio Fund Annual Yield
| SHPAX Fund | USD 19.78 0.44 2.18% |
Health Biotchnology Portfolio fundamentals help investors to digest information that contributes to Health Biotchnology's financial success or failures. It also enables traders to predict the movement of Health Mutual Fund. The fundamental analysis module provides a way to measure Health Biotchnology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Health Biotchnology mutual fund.
Health |
Health Biotchnology Portfolio Mutual Fund Annual Yield Analysis
Health Biotchnology's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, Health Biotchnology Portfolio has an Annual Yield of 0.0%. This indicator is about the same for the Saratoga average (which is currently at 0.0) family and about the same as Health (which currently averages 0.0) category. This indicator is about the same for all United States funds average (which is currently at 0.0).
Health Annual Yield Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Health Biotchnology's direct or indirect competition against its Annual Yield to detect undervalued stocks with similar characteristics or determine the mutual funds which would be a good addition to a portfolio. Peer analysis of Health Biotchnology could also be used in its relative valuation, which is a method of valuing Health Biotchnology by comparing valuation metrics of similar companies.Health Biotchnology is currently under evaluation in annual yield among similar funds.
Fund Asset Allocation for Health Biotchnology
The fund consists of 95.99% investments in stocks, with the rest of investments allocated between different money market instruments.Asset allocation divides Health Biotchnology's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
Health Fundamentals
| Price To Earning | 18.07 X | |||
| Price To Book | 2.64 X | |||
| Price To Sales | 0.75 X | |||
| Total Asset | 4.78 M | |||
| Year To Date Return | 6.53 % | |||
| One Year Return | 10.43 % | |||
| Three Year Return | 4.37 % | |||
| Five Year Return | 6.02 % | |||
| Ten Year Return | 11.34 % | |||
| Net Asset | 11.88 M | |||
| Cash Position Weight | 4.01 % | |||
| Equity Positions Weight | 95.99 % |
About Health Biotchnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Health Biotchnology Portfolio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Health Biotchnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Health Biotchnology Portfolio based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Health Mutual Fund
Health Biotchnology financial ratios help investors to determine whether Health Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Health with respect to the benefits of owning Health Biotchnology security.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |